References:
1. National Research Council: Vitamin B6. Recommended Dietary Allowances, 10th ed. National Academy Press, Washington, DC; 1998.
2. Anon: Vitamin supplements. Med Lett Drugs Ther 1985; 27:66-68.
3. Briggs GG, Freeman RK & Yaffe SJ: Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk, 3rd ed. Williams & Wilkins, Baltimore, MD; 1990.
4. Ross JB & Moss MA: Relief of the photosensitivity of erythropoietic protoporphyria by pyridoxine. J Am Acad Dermatol 1990; 22:340-342.
5. AMA: Drug Evaluations Subscription, vol.3. American Medical Association, Chicago, IL; 1990.
6. Ellis JM, Azuma J, Watanabe T et al: Survey and new data on treatment with pyridoxine of patients having a clinical syndrome including the carpal tunnel and other defects. Re Commun Chem Pathol Pharmacol 1977; 17(1): 165-177.
7. Bennink HJ, Schreurs WH: Improvement of oral glucose tolerance in gestational diabetes by pyridoxine. BMJ 1975; 2(5974): 13-15.
8. Solomon L & Cohen K: Erythrocyte oxygen transport and metabolism and effects of vitamin B6 therapy in type II diabetes mellitus. Diabetes 1989; 38(7): 881-886.
9. Vutyavanich T, Wongtra-Ngan S & Ruangsri R: Pyridoxine for nausea and vomiting of pregnancy: a randomized, double blind, placebo-controlled trial. Am J Obstet Gynecol 1995; 173(3 pt 1): 881-884.
10. Kroll JS: Pyridoxine for neonatal seizures: an unexpected danger. Dev Med Child Neurol 1985; 27: 369-382.
11. Mulrow JP, Mulrow CD & McKenna WJ: Pyridoxine and amiodarone-induced photosensitvity. Ann Intern Med 1985; 103(1): 68-69.
12. Product Information: Hexalen(R), altretamine. U.S. Bioscience, Inc., West Conshohocken, PA, 1999.
13. Mars H: Levodopa, carbidopa, and pyridoxine in Parkinson disease. Metabolic interactions. Arch Neurol 1974; 30(6):444-447.
14. Hsu TH, Bianchine JR, Preziosi TJ et al: Effect of pyridoxine on levodopa metabolism in normal and parkinsonian subjects. Proc Soc Exp Biol Med 1973; 143(2):578-581.
15. Papavasiliou PS, Cotzias GC, Duby SE et al: Levodopa in parkinsonism: potentiation of central effects with a peripheral inhibitor. N Engl J Med 1972; 286(1):8-14.
16. Leon AS, Spiegel HE, Thomas G et al: Pyridoxine antagonism of levodopa in parkinsonism. JAMA 1971; 218(13):1924-1927.
17. Yahr MD & Duvoisin RC: Pyridoxine, levodopa and l-methyldopa hydrazine regimen in parkinsonism. JAMA 1971; 216:2141.
18. Snider DE: Pyridoxine supplementation during isoniazid therapy. Tuber Lung Dis 1980; 61(4):191-196.
19. Bender DA: Vitamin B6 requirements and recommendations. Eur J Clin Nutr 1989; 43(5):289-309.
20. Dalton K & Dalton MJ: Characteristics of pyridoxine overdose neuropathy syndrome. Acta Neurol Scand 1987; 76(1):8-11.
21. Parry GJ & Bredesen DE: Sensory neuropathy with low-dose pyridoxine. Neurology 1985; 35(10):1466-1468.
22. Schaumburg H, Kaplan J, Windebank A et al: Sensory neuropathy from pyridoxine abuse. N Engl J Med 1983; 309(8):445-448.